Trump, Autism and Food and Drug Administration
Digest more
The Food and Drug Administration will review evidence about the safety and efficacy of the abortion drug Mifepristone.
President Donald Trump speaks in the Roosevelt Room of the White House, Monday, Sept. 22, 2025, in Washington, D.C., with Health and Human Services Secretary Robert F. Kennedy Jr., left, and Centers for Medicare & Medicaid Services administrator Dr. Mehmet Oz.
The US Food and Drug Administration is reviewing evidence about the safety and efficacy of mifepristone, one of the drugs used in medication abortion, to investigate how it can be safely dispensed, US Health and Human Services Secretary Robert F.
Consumers are advised to check the expiration date and lot code on the bottom strip of the pouch to determine if their product is part of the recall.
WJW-TV Cleveland on MSN
Baby food recalled in NY, NJ, and other states: FDA
A voluntary recall is in place for a popular baby food sold mostly at a national drug store, according to a company announcement found on the Food and Drug Administration’s website. Sprout Organics has initiated a voluntary recall of one of its products sold at Walgreens.
Wyoming Attorney General Keith Kautz said he joined 21 other states in asking the FDA to investigate an abortion-inducing drug because of a
Crinetics Pharmaceuticals won FDA approval for a drug to treat acromegaly, a rare and debilitating hormonal disorder.
A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially providing an easier alternative to Ozempic injections.
Commercial raw cat food, particularly products sold on shelves at room temperature, may pose a considerable health risk to cats and the families who care for them, according to an analysis of the products.
Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamineGranting of Suitability Petition enables re-filing of Abbreviated New Drug Application (ANDA) for NRx’s patent-pending preservative-free ketamine product WILMINGTON,